Vireo Health International (OTCMKTS:CCHWF) Earns Buy Rating from Echelon Wealth Partners

Echelon Wealth Partners reissued their buy rating on shares of Vireo Health International (OTCMKTS:CCHWF) in a research report released on Tuesday morning, AnalystRatings.com reports. They currently have a $9.50 price target on the stock.

A number of other equities research analysts also recently weighed in on the company. Needham & Company LLC reaffirmed a hold rating on shares of Vireo Health International in a report on Wednesday, September 9th. Canaccord Genuity reaffirmed a buy rating and set a $13.00 price objective on shares of Vireo Health International in a report on Thursday, September 10th.

OTCMKTS CCHWF opened at $3.46 on Tuesday. The firm’s 50 day moving average is $3.57. Vireo Health International has a 1-year low of $0.78 and a 1-year high of $5.30.

About Vireo Health International

Columbia Care Inc produces and sells cannabis in the United States and the European Union. The company was founded in 2012 and is headquartered in New York, New York.

Featured Article: Hedge Funds – How They Work For Investors

Receive News & Ratings for Vireo Health International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vireo Health International and related companies with MarketBeat.com's FREE daily email newsletter.